The DSM IV diagnoses of melancholic and atypical depression in pregnancy
✍ Scribed by Martin Kammerer; Vivette Glover; Claudia Pinard Anderman; Hansjörg Künzli; Alyx Taylor; Brida von Castelberg; Maureen Marks
- Publisher
- Springer Vienna
- Year
- 2010
- Tongue
- English
- Weight
- 119 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1434-1816
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Sixteen patients meeting our criteria for atypical depression were treated in a 7-week single-blind pilot study with cilobamine mesylate, an investigational antidepressant structurally distinct from tricyclic antidepressants (TCA) and monoamine oxidase inhibitors (MAOI). Nine patients (56 per cent)
The objectives of this study were ®rst to compare the responses to moclobemide and sertraline in melancholic and nonmelancholic major depressive patients and secondly to compare the responses of melancholic and nonmelancholic patients in general. Sixty-three patients, with diagnosis of major depress
## Abstract ## Objective We addressed the relatively unexplored use of screening scores measuring __symptoms__ of depression and/or anxiety to aid in identifying patients at increased risk for post‐discharge DSM‐IV Axis I __diagnoses.__ We were unable to find such studies in the literature. ## Me
## Abstract The DSM‐IV and ICD‐10 are both operational diagnostic systems that classify known psychological disorders according to the number of criteria symptoms. Certain discrepancies between the criteria exist and may lead to some inconsistencies in psychiatric research. The purpose of this stud
## Abstract An overview is presented of the rationale, design, and analysis plan for the WMH‐CIDI clinical calibration studies. As no clinical gold standard assessment is available for the DSM‐IV disorders assessed in the WMH‐CIDI, we adopted the goal of calibration rather than validation; that is,